Foamix Pharmaceuticals (NASDAQ:FOMX) Rating Lowered to Sell at Zacks Investment Research – TechNewsObserver
Foamix Pharmaceuticals (NASDAQ:FOMX) Rating Lowered to Sell at Zacks Investment Research TechNewsObserver
Foamix Pharmaceuticals (NASDAQ:FOMX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to …
Source: Investment New Feed